Cargando…

Targeting of STAT5 using the small molecule topotecan hydrochloride suppresses acute myeloid leukemia progression

Acute myeloid leukemia (AML) is a common type of acute leukemia in adults and relapse is one of the main reasons for treatment failure. FLT3-ITD mutations are associated with poor prognosis, short disease-free progression survival and high relapse rates in patients with AML. STAT5 is activated by FL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiahui, Tang, Bin, Miao, Ying, Li, Guihong, Sun, Zhenliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603551/ https://www.ncbi.nlm.nih.gov/pubmed/37830151 http://dx.doi.org/10.3892/or.2023.8645

Ejemplares similares

Pharmacokinetic Comparison of Three Different Administration Routes for Topotecan Hydrochloride in Rats
por: Jeong, Seung-Hyun, et al.
Publicado: (2020)

Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
por: Chen, Huang, et al.
Publicado: (2021)

Andrographolide potentiates the antitumor effect of topotecan in acute myeloid leukemia cells through an intrinsic apoptotic pathway
por: Hodroj, Mohammad Hassan, et al.
Publicado: (2018)

Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression
por: Lin, Qingxiang, et al.
Publicado: (2020)

Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia
por: Lang, Tonio Johannes Lukas, et al.
Publicado: (2023)

Topotecan in the treatment of relapsed small cell lung cancer
por: Quoix, Elisabeth
Publicado: (2008)

Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia
por: Ye, Qi, et al.
Publicado: (2016)

Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain
por: Ojeda, B, et al.
Publicado: (2003)

Development and Validation of a RP-Ultra performance liquid chromatographic Method for Quantification of Topotecan Hydrochloride in Bulk and Injection Dosage Form
por: Saini, P. K., et al.
Publicado: (2010)

Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia
por: Mo, Jianshan, et al.
Publicado: (2023)

Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway
por: Malemud, Charles J.
Publicado: (2010)

TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN
por: Qiu, Qiang, et al.
Publicado: (2023)

Commentary: Periocular topotecan for retinoblastoma
por: Sharma, Minal, et al.
Publicado: (2018)

PB1783: UNRAVELING THE TUMOR SUPPRESSIVE ROLE OF STAT3B IN ACUTE MYELOID LEUKEMIA
por: Edtmayer, Sophie, et al.
Publicado: (2023)

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2023)

Topotecan: An evolving option in the treatment of relapsed small cell lung cancer
por: Garst, Jennifer
Publicado: (2007)

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer
por: Riemsma, Rob, et al.
Publicado: (2010)

Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells
por: Fukushima, Nobuaki, et al.
Publicado: (2016)

Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathway
por: Tan, Jinshui, et al.
Publicado: (2023)

Adhesion molecules in acute myeloid leukemia()
por: Paietta, Elisabeth
Publicado: (1996)

Pharmacologic inhibition of STAT5 in acute myeloid leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2018)

The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
por: Moser, Bernhard, et al.
Publicado: (2021)

Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
por: Minuesa, Gerard, et al.
Publicado: (2019)

Topotecan Monotherapy in Heavily Pretreated Patients with Progressive Advanced Stage Neuroendocrine Carcinomas
por: Olsen, Ingrid Holst, et al.
Publicado: (2014)

Single-molecule observations of topotecan-mediated TopIB activity at a unique DNA sequence
por: Koster, Daniel A., et al.
Publicado: (2008)

Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma
por: Blanchette, P., et al.
Publicado: (2012)

Periocular topotecan for vitreous seeds in retinoblastoma
por: Sthapit, Purnima R, et al.
Publicado: (2018)

Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature
por: Vennepureddy, Adarsh, et al.
Publicado: (2015)

Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia
por: Liu, Yiman, et al.
Publicado: (2022)

Topotecan-Based Combination Chemotherapy in Patients with Transformed Chronic Myelogenous Leukemia and Advanced Myelodysplastic Syndrome
por: Park, Soo Jeong, et al.
Publicado: (2000)

Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model
por: Kuehl, Philip J., et al.
Publicado: (2018)

Optimization of liposomal topotecan for use in treating neuroblastoma
por: Chernov, Lina, et al.
Publicado: (2017)

A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression
por: He, Yuan, et al.
Publicado: (2021)

Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD(+) Acute Myeloid Leukemia
por: Bregante, Javier, et al.
Publicado: (2021)

Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells
por: Hallal, Rawan, et al.
Publicado: (2020)

Development and Validation of an HPLC Method for Analysis of Topotecan in Human Cerebrospinal Fluid and Its Application in Elimination Evaluation of Topotecan after Intraventricular Injection
por: Yoshikawa, Naoki, et al.
Publicado: (2021)

The Lipophilic Purine Nucleoside—Tdp1 Inhibitor—Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo
por: Chernyshova, Irina A., et al.
Publicado: (2022)

Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients
por: Horita, Nobuyuki, et al.
Publicado: (2015)

Evaluation of topotecan monotherapy for relapsed small-cell lung cancer after amrubicin monotherapy failure
por: Fujita, Kohei, et al.
Publicado: (2021)

Myeloid cell leukemia-1 is an important predictor of survival and progression of small cell lung cancer
por: Zhou, Ting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_81b6q53ta74plk2ndiff5i5jch